Oral platelet glycoprotein IIb/IIIa inhibitors.
Kereiakes
D J
DJ
Carl and Edyth Lindner Center for Clinical Cardiovascular Research, University of Cincinnati College of Medicine, Ohio, USA. lindner@healthall.com
D000208:Acute Disease; D000284:Administration, Oral; D002986:Clinical Trials as Topic; D006801:Humans; D017202:Myocardial Ischemia / Q000628:therapy*; D009204:Myocardial Revascularization / Q000379:methods; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015912:Thrombolytic Therapy / Q000379:methods
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex